Treatment of localized neuropathic pain of different etiologies with the 5% lidocaine medicated plaster – a case series

Figures & data

Table 1 Pain diagnoses and pain location. Two patients discontinued after 4, and one patient after 5 treatment months

Pain diagnosis	n	Pain location	Overall pain intensity (NRS0–10)
			Baseline	After 6 months treatment
Dorsalgia	17	Lumbar region	8	4
			7	5.5
			9	4
			10	3
			8.5	2
			8	4 (after 4 months)
		Left popliteal fossa	10	4
		Left hip and leg	6	1
		Left lower leg	10	4
		Lumbar and cervical region	7.5	9
			6.5	1
			8	4
		Lumbar and thoracic region	8.5	8
		Lumbar region and forehead	10	7
		Cervical, thoracic, lumbar region	7	0
		Cervical regiona	9	2.5 (after 5 months)
		Cervical and thoracic region	8	6
Postoperative/posttraumatic pain	8	Left mandible	7	1.5
		Left hipa	9	2.5 (after 5 months)
		Right ankle	8.5	1
		Left hand	9	3
		Right wrist	9.5	0
		Left groin	10	5
		Thoracic	7	3
			9	0
Phantom limb pain	1	Stump left leg	10	1
Postherpetic neuralgia	1	Thoracic, left side	9	6
Not specified	1	Left wrist	8	3.5 (after 4 months)

Note:

a This patient experienced neuropathic pain in the cervical region and following hip surgery.

Abbreviation: NRS, numerical rating scale.

Figure 1 Reduction in mean overall pain intensity, neuralgiform pain, and burning pain following treatment with the 5% lidocaine medicated plaster (n=27 baseline to 4 months, n=25 at 5 months, n=24 at 6 months).